Evidence map›Paper›PMID 35426497›Full record

ReviewAbdominal radiology (New York)2022

PET/CT and PET/MRI in neuroendocrine neoplasms.

Naveen Rajamohan, Hala Khasawneh, Aparna Singh, Garima Suman, Geoffrey B Johnson, Shounak Majumder, Thorvardur R Halfdanarson, Ajit H Goenka

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Abdominal radiology (New York), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Reduction of [EJNMMI physics · 2024
    Article
  6. Review
  7. Prospective comparison of [EJNMMI research · 2023
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Naveen RajamohanDepartment of Radiology, Mayo Clinic, 200 First Street SW, Charlton 1, Rochester, MN, 55905, USA.
Hala KhasawnehDepartment of Radiology, Mayo Clinic, 200 First Street SW, Charlton 1, Rochester, MN, 55905, USA.
Aparna SinghDepartment of Radiology, Mayo Clinic, 200 First Street SW, Charlton 1, Rochester, MN, 55905, USA.
Garima SumanDepartment of Radiology, Mayo Clinic, 200 First Street SW, Charlton 1, Rochester, MN, 55905, USA.
Geoffrey B JohnsonDepartment of Radiology, Mayo Clinic, 200 First Street SW, Charlton 1, Rochester, MN, 55905, USA.
Shounak MajumderDepartment of Gastroenterology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Thorvardur R HalfdanarsonDepartment of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Ajit H GoenkaDepartment of Radiology, Mayo Clinic, 200 First Street SW, Charlton 1, Rochester, MN, 55905, USA. goenka.ajit@mayo.edu.ORCID 0000-0002-7804-2695
Mayo Clinic · US

Funding

Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid BiopsyR01CA256969 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Eric Collisson, Ajit Harishkumar Goenka · 2021 to 2026
$3.1M
Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)R01CA272628 · NCI · MAYO CLINIC ROCHESTER · PI GOENKA, AJIT HARISHKUMAR · 2022 to 2025
$2.5M
NCI NIH HHS R01 CA256969NCI NIH HHS R01 CA272628
6 · The paper itself

Abstract

Advanced molecular imaging has come to play an integral role in the management of gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs). Somatostatin receptor (SSTR) PET has now emerged as the reference standard for the evaluation of NENs and is particularly critical in the context of peptide receptor radionuclide therapy (PRRT) eligibility. SSTR PET/MRI with liver-specific contrast agent has a strong potential for one-stop-shop multiparametric evaluation of GEP-NENs.

Indexed as

Neuroendocrine TumorsPancreatic NeoplasmsHumansMagnetic Resonance ImagingPositron-Emission TomographyPositron Emission Tomography Computed TomographyReceptors, SomatostatinReceptors, SomatostatinFluorodeoxyglucose F18Gallium radioisotopesMagnetic resonance imagingNeuroendocrine tumorsPositron emission tomography-computed tomography

Identifiers

PMID35426497
PMCPMC12994855
OpenAlexW4223931047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.